Legend Biotech Corporation (LEGN) short interest & options flow
NASDAQLegend Biotech enters its November 10 earnings release with short interest still falling but the lending market tightening to its most constrained level in months, a tension that has sharpened since Monday's note. The short-covering story flagged earlier this week has continued. Short interest now stands at 8.3% of the free float, down 14% on the week from a mid-October peak near…
LEGN short interest surges 22% in one week to 11% of float, highest level since June, as availability plummets 56% to 24%.
- Market cap
- $4.41B
- Next earnings
- 10 Nov 2026
Key data as of 5 Nov 2026

LEGN news and analysis
RSSNo long-form analysis yet for LEGN. Pulse alerts and the live data picture are available on ORTEX.
Open LEGN on ORTEX →Want the live picture for LEGN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LEGN — free to start on ORTEX.
Sign up for free →Open LEGN on ORTEX